Charles River launches press release ahead of AACR for its end-to-end Oncology Discovery capabilities, with the Cypre platform featured as a critical step for in vitro pharmacology and drug screening prior to IND.
Charles River launches press release ahead of AACR for its end-to-end Oncology Discovery capabilities, with the Cypre platform featured as a critical step for in vitro pharmacology and drug screening prior to IND.